Successful Completion of $32 million Entitlement Offer
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Starpharma Holdings Limited announces the successful completion of its entitlement offer to raise funds through the issuance of new shares, which received strong support from shareholders. The offer closed with a high take-up rate and included provisions for oversubscription by existing shareholders. The funds raised will support ongoing clinical programs and the advancement of oncology assets within Starpharma's portfolio. The company expresses gratitude to participants for their support and highlights its strategic focus on building a high-value pipeline.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Starpharma Holdings Limited on 6ix
Story so far
Earlier from Starpharma
- Application for quotation of securities - SPL
- Entitlement Offer Investor Presentation
- Fully Underwritten Entitlement Offer to Raise $32 Million
- Quarterly Activities Report and Appendix 4C
- DEP milestone triggers partner option fee
Later from Starpharma
- Becoming a substantial holder
- Change of Director Interest Notice - C Maley
- Change of Director Interest Notice - J Davies
- Change of Director Interest Notice - L Cheng
- Change of Director Interest Notice - R Thomas
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma